Plunkett Research Online: Ironwood Pharmaceuticals Inc

IRONWOOD PHARMACEUTICALS INC (IRWD:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const.....



Ironwood Pharmaceuticals Inc
Ticker: IRWD
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 621-7722
Fax: 617 494-0480
Address: 100 Summer Street
Suite 2300
Boston, MA 02110 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Discovery & Development
Gastrointestinal Care
Clinical Testing
Drug Development
Drug Discovery
Drug Commercialization
Contacts Description
Thomas McCourtCEO/Director/President
Sravan EmanyCFO/Senior VP
See More
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
LINZESS
CONSTELLA
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: